Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 117,368 | 83,635 | 146,252 | 60,225 | 33,016 |
| Marketable Securities | 188,451 | 110,349 | 62,423 | 57,298 | 100,011 |
| Receivables | 2,426 | 2,789 | 2,997 | 3,594 | 6,755 |
| Other current assets | 1,084 | 535 | 276 | 153 | 0 |
| TOTAL | $315,606 | $204,151 | $217,466 | $125,986 | $145,311 |
| Non-Current Assets | |||||
| PPE Net | 1,462 | 1,459 | 1,553 | 1,603 | 1,681 |
| Investments And Advances | 2,000 | 6,025 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,400 | 5,685 | 5,961 | 7,312 | 7,925 |
| TOTAL | $8,862 | $13,169 | $7,514 | $8,915 | $9,606 |
| Total Assets | $324,468 | $217,320 | $224,980 | $134,901 | $154,917 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,807 | 4,874 | 3,858 | 4,820 | 4,052 |
| Accrued Expenses | 18,498 | 15,518 | 12,917 | 11,616 | 12,360 |
| TOTAL | $40,241 | $38,563 | $35,360 | $36,372 | $35,406 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 9,832 | 9,794 |
| Deferred Revenues | 14,477 | 16,765 | 17,230 | 18,630 | 17,738 |
| Other Non-Current Liabilities | 4,621 | 5,055 | 5,351 | 5,616 | 5,961 |
| TOTAL | $4,621 | $9,167 | $22,135 | $35,863 | $39,547 |
| Total Liabilities | $44,862 | $47,730 | $57,495 | $72,235 | $74,953 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,808 | 38,257 | 36,807 | 27,435 | 27,294 |
| Retained earnings | -283,811 | -264,925 | -257,162 | -237,741 | -217,661 |
| Other shareholders' equity | 28 | -88 | -208 | 107 | -221 |
| TOTAL | $279,606 | $169,590 | $167,485 | $62,666 | $79,964 |
| Total Liabilities And Equity | $324,468 | $217,320 | $224,980 | $134,901 | $154,917 |